Alivus Life Sciences Ltd. (GLS)
Market Closed
12 Aug, 10:00
XNSE MSE Primary XNSE ₹
1,361. 00
-32.6
-2.3393%
₹
- Market Cap
- P/E Ratio
- Div Yield
82,193 Volume
- Eps
₹ 1,393.6
Previous Close Want to track GLS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
GLS Earnings Reports FAQ
What is the earnings per share (EPS) for GLS?
EPS data for GLS is currently not available, as Alivus Life Sciences Ltd has not reported recent earnings.
What is the company's earnings growth rate?
Alivus Life Sciences Ltd has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Alivus Life Sciences Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Alivus Life Sciences Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for GLS at this time, as Alivus Life Sciences Ltd has no recent EPS data to calculate it.
